Every few months, a fintech company with strong revenue growth but deep losses files for an IPO. Retail investors face the same dilemma: the growth story is real, the losses are real, the GMP is exciting – and nobody is quite sure how to think about it.
Turtlemint Fintech Solutions, which opened for subscription on June 19, 2026, is a textbook example. Rs 748 crore in revenue for 9 months of FY26. Rs 187 crore of losses in the same period. A Rs 882 crore IPO. GMP of Rs 30-40 the day before opening.
Here is a framework for evaluating exactly this kind of IPO – one that you can apply to Turtlemint today and to every similar IPO that follows.
Why Loss-Making Companies Get Listed
A company listing while loss-making is not inherently a red flag. Zomato, Nykaa, and Paytm all listed with losses. Some recovered (Zomato turned profitable by FY24), some have not (Paytm). The question is never “are they profitable?” – it is “what is the path to profitability and how credible is it?”
Loss-making IPOs get listed because:
- Founders and early investors want liquidity
- Growth-phase companies often reinvest all margins into expansion
- Institutional markets have shifted to valuing future cash flows, not current profits
The risk for retail investors is that they often pay full price for a business still proving its model.
The 5-Point Framework
1. Revenue quality – is it growing and is it real?
Look at operating revenue growth year-over-year, not just the headline number. Check whether revenue is recurring (subscriptions, renewals) or transactional (one-time commissions). Recurring revenue is worth more.
For Turtlemint: Rs 693 crore in full FY25 vs Rs 748 crore in just 9 months of FY26. That is an annualised run rate of roughly Rs 1,000 crore – a clear upward trajectory. Their revenue is commission-based (insurance distribution), which has some churn risk but is relatively predictable.
2. Loss trajectory – are losses narrowing or widening?
A company burning Rs 100 crore a year with revenues growing 60% is very different from one burning Rs 100 crore with 10% revenue growth. The ratio of losses to revenue is the metric to track.
For Turtlemint: Rs 187 crore loss on Rs 748 crore revenue = a 25% loss margin. Compare that to the full FY25 ratio – if that number is shrinking, the business is moving toward profitability. If it is widening, alarm bells should ring.
3. Unit economics – does the core business make money?
Strip out one-time costs, expansion costs, and corporate overheads. Does the core transaction – selling one insurance policy through one agent – generate a contribution margin? Look for gross margin in the DRHP.
High gross margin with losses at the net level usually means the company is spending heavily on growth (sales, tech, people). This is fixable. Low gross margin means the core model may not work at scale – this is a structural problem.
4. Cash runway – how long before they need more money?
A company raising Rs 660 crore in fresh issue money needs to demonstrate it can use that capital to reach cash flow positive before needing to raise again. Calculate: current cash burn rate vs fresh issue size = months of runway.
If the runway is less than 18 months and the path to profitability is not clear, the IPO is essentially asking you to fund their next round at a public market price.
5. Promoter and institutional intent – what does OFS tell you?
In a mix of fresh issue and Offer for Sale (OFS), OFS money goes to existing shareholders, not the company. Turtlemint’s issue is Rs 660 crore fresh + Rs 221 crore OFS. That Rs 221 crore is existing investors cashing out at your expense.
A high OFS component relative to fresh issue is a yellow flag – it means insiders are using the IPO as an exit, not just a capital raise. In Turtlemint’s case, OFS is about 25% of the total issue, which is within normal range.
What GMP Actually Tells You
Grey Market Premium is a black market signal of speculative demand for an IPO before listing. It tells you what arbitrage traders think the listing price will be. It does not tell you the intrinsic value of the business.
A GMP of Rs 35 on a Rs 152 issue price means some traders expect listing at Rs 187. That expectation can be self-fulfilling on day one and completely irrelevant by day thirty.
Applying for an IPO purely based on GMP is speculation, not investing. Use GMP to gauge sentiment, not to make the apply/skip decision.
Applying the Framework to Turtlemint
- Revenue quality: Strong, accelerating, recurring-ish. Positive.
- Loss trajectory: Needs checking against FY24 and FY25 ratios. DRHP is the source.
- Unit economics: Insurance distribution typically has decent gross margins. The DRHP’s cost breakdown will show how much goes to agent commissions vs platform costs.
- Cash runway: Rs 660 crore fresh at ~Rs 250 crore annualised burn = roughly 2.5 years. Adequate if growth continues compressing losses.
- OFS ratio: 25% – acceptable.
Overall: Turtlemint is not obviously a trap. It is a genuine business in a large market (Indian insurance distribution) with a credible model. The question is price – Rs 152 per share values the company at roughly Rs 2,700-3,000 crore. At Rs 1,000 crore annualised revenue and losses, that is a 2.7-3x P/S ratio. Not outrageous for a fast-growing fintech, but not cheap either.
The Decision Framework
Apply if: You are comfortable holding for 12-18 months, you have verified the loss trajectory is narrowing, and you can absorb a 20-30% post-listing correction.
Skip if: You are applying for listing gains only, you have not read the DRHP, or you are relying entirely on GMP.
This post is for educational purposes only. IPO investments carry risk. Read the DRHP and consult a registered advisor before investing.